755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial
Conclusion: The additional use of picosecond laser therapy showed no clinical difference except for subtle differences detected by RCM assessments.The study was registered in the Chinese Clinical Trial Registry (ChiCTR2100051294; 18 September 2021).
Source: Lasers in Medical Science - Category: Laser Surgery Source Type: research
More News: Biomedical Science | China Health | Clinical Trials | Laser Surgery | Laser Therapy | Science | Skin | Study